Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: In vivo and in vitro evidence

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 8-14

  Pelissier, T ^a,b   Alloui, A ^a   Caussade, F ^c   Dubray, C ^a   Cloarec, A ^c   Lavarenne, J ^a   Eschalier, A ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b Facultad de Odontologia   (Chile)

^c UPSA Laboratories   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; INDOMETACIN; MU OPIATE RECEPTOR; NALOXONE; PARACETAMOL; PROPACETAMOL; PROSTAGLANDIN; RADIOLIGAND; SEROTONIN 3 RECEPTOR; TROPISETRON; YOHIMBINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIGAND BINDING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SUBCUTANEOUS DRUG ADMINISTRATION; VOCALIZATION;

ACETAMINOPHEN; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NALOXONE; PAIN MEASUREMENT; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; VOCALIZATION, ANIMAL;

EID: 0030426275     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. th International Congress of Pharmacology, Montréal, July 24-29, 1994.
2. 3H]clonidine and [H]rauwolscine. Eur. J. Pharmacol. 106: 141-147, 1985.
3. BANNWARTH, B., MEMOTES-MAINARD, F., SCHAEVERBEKE, T., LEBAT, L. AND DEHAIS, J.: Central analgesic effects of aspirin-like drugs. Fundam. Clin. Pharmacol. 9: 1-7, 1995.
4. BANNWARTH, B., NETTER, P., LAPICQUE, F., GILLET, P., PÉRÉ, P., BOCCARD, E., ROYER, R. J. AND GAUCHER, A.: Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br. J. Clin. Pharmacol. 34: 79-81, 1992.
5. BANNWARTH, B., NETTER, P., LAPICQUE, F., GILLET, P., PÉRÉ, P., THOMAS, P. AND GAUCHER, A.: Plasma and cerebrospinal fluid concentrations of indomethacin in humans: Relationship to analgesic activity. Eur. J. Clin. Pharmacol. 38: 343-346, 1990.
6. 3H-SCH23390, a selective D1 receptor antagonist ligand, in rat striatum. Life Sci. 35: 1885-1893, 1984.
7. BIPPI, H. AND FRÖHICH, J. C.: Effects of acetylsalicylic acid and paracetamol alone and in combination on prostanoid synthesis in man. Br. J. Clin. Pharmacol. 29: 305-310, 1990.
8. BJÖRKMAN, R., HALLMAN, K. M., HENDER, T. AND HENNING, M.: Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain 57: 259-264, 1994.
9. BROMM, B., RUNDSHAGEN, I. AND SCHAREIN, E.: Central analgesic effects of acetylsalicylic acid in healthy men. Arzneim. Forsch. Drugs 41: 1123-1129, 1991.
10. BRUCCHAUSEN, F. V. AND BAUMANN, J.: Inhibitory actions desacetylation products of phenacetin and paracetamol on prostaglandin synthetases in neuronal and glial cell lines and rat renal medulla. Life. Sci. 30: 1783-1791, 1982.
11. BRUNE, K, BECK, W. S., GEISSLINGER, G., MENZEL-SOGLOWEK, S., PESKAR, B. M. AND PESKAR, B. A.: Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experiencia (Basel) 47: 257-261, 1991.
12. BRUNE, K: Spinal effects of antipyretics. Drugs 47: 21-27, 1994.
13. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 29: 331-346, 1986.
14. BYLUND, D. B. AND SNYDER, S. H.: Beta-adrenergic receptor binding in membrane preparations for mammalian brain. Mol. Pharmacol. 12: 568-580, 1976.
15. CARLSSON, K. H., MONZEL, W. AND JURNA, I.: Depression by morphine and the non-opoid analgesic agents, metamizol (dipyrone), lysine acetylsalicylate and paracetamol of activity in rat thalamus neurons evoked by electrical stimulation of nociceptive afferents. Pain 32: 313-326, 1988.
16. CHAPMAN, V. AND DICKENSON, A. H.: The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rat. Eur. J. Pharmacol. 219: 427-433, 1992.
17. CHEN, A. C. N. AND CHAMAN, C. R.: Aspirin analgesia evaluated by event-related potentials in man: Possible central action in brain. Exp. Brain Res. 39: 359-364, 1980.
18. 4 receptors: Naughty, but nice. Trends Pharmacol. Sci. 10: 385-386, 1989.
19. CLISSOLD, S. P.: Paracetamol and phenacetin. Drugs 32: 46, 1986.
20. DEMBINSKA-KIEC, A., ZMUDA, A. AND KRUPINSKA, J.: Inhibition of prostaglandin synthetase by aspirin-like drugs in different microsomal preparations. In Advances in Prostaglandins and Thromboxane Research, ed. by B. Samuelsson and R. Paoletti, (eds) Vol. 1, pp. 99-103, Raven Press, New York, 1976.
21. DEPRÉ, M., VAN HECKEN, A., VERBESSELT, R., TJANDRA-MAGA, T. B., GERIN, M. AND DE SCHEPPER, J. P.: Tolerance and pharmacokinetics of propacetamol, a paracetamol formulation for intravenous use. Fundam. Clin. Pharmacol. 6: 259-262, 1992.
22. ENNA, S. J. AND SNYDER, S. H.: Properties of τ-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions. Brain Res. 100: 81-97, 1975.
23. 2 levels in mouse brain. Eur. J. Pharmacol. 179: 25-34, 1990.
24. FERREIRA, S. H., LORENZETTI, B. B. AND CORREA, F. M. A.: Central and peripheral analgesic actions of aspirin-like drugs. Eur. J. Pharmacol. 53: 39-48, 1978.
25. FLOWER, R. J. AND VANE, J. R.: Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetaminophenol). Nature (Lond.) 240: 410-411, 1972.
26. FORREST, J. A. M., CLEMENTS, J. A. AND PRESCOTT, L. F.: Clinical pharmacokinetic of paracetamol. Clin. Pharmacokinet. 7: 93-107, 1982.
27. GAZZARD, S. P., FORD-HUTCHINSON, A. W., SMITH, M. J. H. AND WILLIAMS, R.: The binding of paracetamol to plasma proteins of man and pig. J. Pharm. Pharmacol. 25: 964-967, 1973.
28. 3 binding sites in rat spinal cord synaptosomal membranes. Eur. J. Pharmacol. 156: 287-290, 1988a.
29. 3 receptor antagonist. Neurosci. Lett. 95: 313-317, 1988b.
30. GRANADOS-SOTO, V., FLORES-MURRIETA, F. J., LOPEZ-MUNOZ, F. J., SALOZAR, L. A., VILLAHREAL, J. E. AND CASTA NEDA-HERNANDEZ, G.: Relationship between paracetamol plasma levels and its analgesic effect in the rat. J. Pharma. Pharmacol. 44: 741-744, 1992.
31. GROPETTI, A., BRAGA, P. C., BIELLA, G., PARENTI, M., RUSCONI, L. AND MARTEGAZZA, P.: Effects of aspirin on serotonin and met-enkephalin in brain. Neuropharmacology 27: 499-505, 1988.
32. 8]-SP (6-11) (senktide): New selective radioligands for NK-1 and NK-3 tachykinin receptors. Biotrechnol. Update (DuPont Nemours) 6: 4-8, 1991.
33. 3H]paroxetine binding to rat cortical membranes. Eur. J. Pharmacol. 118: 107-114, 1985.
34. 3H]spiroperidol. Mol. Pharmacol. 26: 439-451, 1984.
35. HUNSKAAR, S., BEROE, O. G. AND HOLE, K.: Dissociation between antinociceptive and anti-inflammatory effects of acetylsalycilic acid and indomethacin in the formalin test. Pain 25: 125-132, 1986.
36. HUNSKAAR, S., FASMER, O. B. AND HOLE, K.: Acetylsalicylic acid, paracetamol and morphine inhibit behavioral responses to intrathecally administered substance P or capsaicin. Life Sci. 37: 1835-1841, 1985.
37. HUNSKAAR, S., ROSLAND, J. H. AND HOLE, K.: Mechanisms of orphenadrine-induced antinociception in mice: A role for serotonergic pathways. Eur. J. Pharmacol. 160: 83-91, 1989.
38. JURNA, I. AND BRUNE, K.: Central effect of nonsteroid anti-inflammatory agents, indomethacin, ibuprofen, determined in C fiber-evoked activity in single neurons of the rat thalamus. Pain 41: 71-80, 1990.
39. KAYSER, V., DEMEULES, J. AND GUILBAUD, G.: Effects of noradrenergic agonists on animal chronic pain models: Arthritic and mononeuropathic rats. In Towards the Use of Noradrenergic Agonists for the Treatment of Pain, ed by J. M. Besson and G. Guilbaud, pp. 151-167, Elsevier, Amsterdam, 1992.
40. KAYSER, V. AND GUILBAUD, G: Local and remote modifications of nociceptive sensitivity during carragenin-induced inflammation in the rat. Pain 28: 99-107, 1987.
41. LANZ, R., POLSTER, P. AND BRUNE, K.: Antipyretic analgesics inhibit prostaglandin release from astrocytes and macrophages similarly. Eur. J. Pharmacol. 130: 105-109, 1986.
42. 3H]desipramine binding associated with neuronal norepinephrine uptake sites in rat brain membranes. J. Neurosci. 2: 1515-1525, 1982.
43. 2 receptor binding sites. Binding properties, brain distribution and functional role. Mol. Pharmacol. 21: 301-314, 1982.
44. MALMBERG, A. B. AND YAKSH, T. L.: Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther. 263: 135-146, 1992.
45. MARTIN, G. R. AND HUMPHREY, P. P. A.: Receptors for 5-hydroxytryptamine: Current perspectives on classification and nomenclature. Neuropharmacology 33: 261-273, 1994.
46. MARTIN, I. L.: The benzodiazepine receptor. In Neuromethods-4-Receptors Binding, ed. by A. A. Boulton, G. B. Baker and P. D. Hrdina, pp. 415-453, Humana Press, Clifton, 1986.
47. MCCORMACK, K.: Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 59: 9-43, 1994.
48. MCQUAY, H. G., POPPLETON, P., CAROLL, D., SUMMERFIELD, R. J., BULLINGOHAM, R. E. S. AND MOORE, R. A.: Ketorolac and acetaminophen for orthopedic postoperative pain. Clin. Pharmacol. Ther. 39: 89-93, 1986.
49. MENASSÉ, R., HEDWALL, P. R., KRAETZ, J., PERICIN, C., RIESTERER, L., SALLMANN, A., ZIEL, R. AND JAQUES, R.: Pharmacological properties of diclofenac sodium and its metabolites. Scand. J. Reumatol. 22: 5-6, 1978.
50. MESTRE, C., PELISSIER, T., FIALIP, J., WILCOX, G. AND ESCHALIER, A.: A method to perform direct transcutenous intrathecal injection in rats. J. Pharmacol. Toxicol. Methods 4: 197-200, 1994.
51. 1 recognition site. Eur. J. Pharmacol. 90: 151-153, 1983.
52. 3H]prazosin binding. Mol. Pharmacol. 29: 321-330, 1986.
53. 3 binding sites in rat brain cortical membranes. Biochem. Pharmacol. 38: 1693-1695, 1989.
54. NIELSEN, J. C., BJERRING, P., ARENT-NIELSEN, P. AND PETTERSON, K. J.: Analgesic efficacy of immediate and sustained release paracetamol and plasma concentration of paracetamol. Double blind, placebo-controlled evaluation using painful laser stimulation. Eur. J. Clin. Pharmacol. 42: 261-264, 1992.
55. OCHS, H. R., GREENBLATT, D. J., ABERNETHY, D. R., ARENDT, R. M., EICHELKRALT, W. AND HAHN, N.: Cerebrospinal fluid uptake and peripheral distribution of centrally acting drugs: Relation to lipid solubility. J. Pharm. Pharmacol. 37: 428-431, 1985.
56. 1B receptors in the brain of the rat. J. Pharmacol. Exp. Ther. 244: 144-153, 1988.
57. 3 receptors. NeuroReport 6: 1546-1548, 1995.
58. 3 Receptor-Mediated Antinociceptive Effect of Paracetamol, 7th World Congress on Pain, August 22-27, Paris, 1993.
59. PILETTA, P., PORCHET, H. C. AND DAYER, P.: Central analgesic effect of acetaminophen but not aspirin. Clin. Pharmacol. Ther. 49: 350-354, 1991.
60. RICHARDSON, B. P., ENGEL, G., DONATSCH, P. AND STADLER, P. A.: Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature (Lond.) 316: 126-131, 1985.
61. 1C receptors in the choroid plexus. J. Pharmacol. Exp. Ther. 247: 169-173, 1988.
62. 6-phenylisopropyladenosine. Naunyn-Schmiedeberg's Arch. Pharmacol. 313: 179-187, 1980.
63. 4 and cyclic AMP in patients with rheumatoid arthritis. Scand. J. Rheumatol. 19: 71-75, 1990.
64. 3H]dopamine uptake. Neurochem. Inst. 15: 325-332, 1989.
65. 3H]CGP 39653: A new N-methyl-D-aspartate antagonist radioligand with nanomolar affinity in rat brain. Eur. J. Pharmacol. 192: 19-24, 1991.
66. SKOGLUND, L. A., SOKJELBRED, P. AND FYLLINGEN, G.: Analgesic efficacy of acetaminophen, 100 mg, acetaminophen, 2000 mg, and the combination of acetaminophen, 1000 mg and codeine phosphate, 60 mg, versus placebo in acute postoperative pain. Pharmacotherapy 11: 364-369, 1991.
67. 3H]ethylketazocine binding at the κ-opi-oid sites. Can. J. Physiol. Pharmacol. 66: 1368-1372, 1988.
68. TJØLSEN A. LUND, A. AND HOLE, K.: Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems. Eur. J. Pharmacol. 193: 193-201, 1991.
69. TOLMAN, E. L., FULLER, B. L., MARINAN, B. A., CAPETOLA, R. J., EVINSON, S. R. AND ROSENTHALE, M. E.: Tissue selectivity and variability of effects of acetaminophen on arachidonic acid metabolism. Prostaglandins Leukotrienes Med. 12: 347-356, 1983.
70. 1-receptors: Differential effect of sodium ions on the binding of two radioligands. Br. J. Pharmacol. 103: 1745-1751, 1991.
71. VANE, J. R.: Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature (Lond.) 231: 232-235, 1971.
72. VON MEYRING, J.: Beitrage zur kenntniss der antipyretica. Ther. Monatsh. 7: 577-587, 1893.
73. 3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. Characterization and regulation of agonist binding to putative muscarinic subtypes. J. Pharmacol. Exp. Ther. 237: 411-418, 1986.
74. 3 Receptors and Pain, ed. by M. Hamon, pp. 275-300, Academic Press, London, 1992.
75. WOOD, P. L.: Multiple opioid receptors in the central nervous system. In Neuromethods-4- Receptor Binding, ed. by A. A. Boulton, G. B. Baker and P. D. Hrdina, pp. 329-363, Humana Press, Clifton, 1986.